enGene Corp (ENGN) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Shimoliy Amerikada ishlanmalarni lokalizatsiya qilish enGene Holdings Inc. (ENGN) kompaniyasiga intellektual mulk himoyasi va kapitalga ishonchli kirish imkoniyatini taqdim etadi. Biroq, kompaniya ma'lum komponentlar yetkazib berish zanjiridagi uzilishlar va tashqi savdo cheklovlariga nisbatan zaif bo'lib qolmoqda. GURU.Markets platformasidagi ushbu kunlik narxlar dinamikasi aktivning tendentsiyasini aks ettiradi, uning qarzdorlikning o'z kapitaliga nisbati 0.14 ni tashkil etadi, biznes esa qovuq o'smalari davolash bo'yicha qo'shma klinik sinovlarga tayanadi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_ENGN_-_enGene-Holdings-Inc._-_Long-Term-Debt-to-Capital "ENGN: enGene Uzoq muddatli qarzning kapitalga nisbati 21.02.2024 - 01.11.2026 | 👁️GURU.Markets👁️")
enGene Holdings Inc. (ENGN) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati enGene Holdings Inc.|ENGN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati engene.com|ENGN - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati enGene Holdings Inc.|ENGN - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi enGene|Tezkor likvidlik ko‘rsatkichi engene.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:enGene Holdings Inc - ENGN
Tayyor mahsulotlardan barqaror pul oqimlariga ega bo'lmagan enGene Holdings Inc. (ENGN) uchun kapital tuzilmasidagi uzoq muddatli kreditlarning ulushi tadqiqot va ishlanmalarni (R&D) qo'llab-quvvatlash uchun tashqi qarzlarga bo'lgan bog'liqlikning ko'rsatkichi bo'lib xizmat qiladi. Ushbu metrika muddati bir yildan ortiq bo'lgan majburiyatlarni bozor kapitalizatsiyasi bilan solishtiradi, bu esa investorlarga kompaniyaning moliyaviy barqarorligini va dastlabki sinov bosqichlarida haddan tashqari katta qarz yuklamasi xavfini baholash imkonini beradi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Septerna Corp - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Pieris Corp|Savara Inc. (SVRA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi RIGL|ANAB (AnaptysBio) - Uzoq muddatli qarzning kapitalga nisbati|ATXS - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati RAPT|JBIO - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Aclaris Therapeutics ACRS|KYTX: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Tiziana Life Sciences Ltd - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Cabaletta Bio Inc.|VTYX (Ventyx Bio) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Theratechnologies, Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|AVTX (Avalo Therapeutics, Inc) - Uzoq muddatli qarzning kapitalga nisbati|ELDN: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Agenus Inc. (AGEN)|CLYM - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Zura Bio Limited ZURA|aTyr Pharmaceuticals - Uzoq muddatli qarzning o'z kapitaliga nisbati|Adagene Corp - Uzoq muddatli qarzning kapitalga nisbati|IMA (ImageneBio Inc) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|STTK: Uzoq muddatli qarzning kapitalga nisbati|EQ - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Connect Biopharma Holdings|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi IMUX (Immunic Inc)|Uzoq muddatli qarzning kapitalga nisbati ATRA|inflarx.de (IFRX) - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati X4 Pharmaceuticals, Inc. XFOR|Uzoq muddatli qarzdorlikning kapitalga nisbati Adicet Bio Inc. (ACET)|CELU: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti INMB (INmune Bio Corporation)|BRNS: Uzoq muddatli qarzning kapitalga nisbati|KZR - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati SAB Biotherapeutics, Inc.|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi AKTX (Akari Therapeutics PLC)|Uzoq muddatli qarzning kapitalga nisbati ENLV|Uzoq muddatli qarzning o'z kapitaliga nisbati q32bio.com QTTB|GeoVax Labs, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati edesabiotech.com (EDSA)|iBio - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Carisma Therapeutics|XTL Biopharmaceuticals, Ltd. (XTLB) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BOLT|HCWB (HCW Biologics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|APVO - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM ImmunoTech (AIM)|aditxt.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati GRI Bio Corp GRI|XRTX (XORTX Corp) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Vyome Holdings Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti REVB (revbiosciences.com)|INDP: Uzoq muddatli qarzning kapitalga nisbati|Scinai Immunotherapeutics Ltd (SCNI) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CalciMedica Inc|AFMD: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Allakos Inc. (ALLK)|Uzoq muddatli qarzning o'z kapitaliga nisbati hookipapharma.com HOOK|Uzoq muddatli qarzning kapitalga nisbati IGMS (IGM Biosciences)|Uzoq muddatli qarzning kapitalga nisbati iTeos Therapeutics Inc ITOS|OCEA: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TCBP (TC BioPharm Ltd)|THRD: Uzoq muddatli qarzning kapitalga nisbati